Molecular profiling of advanced solid tumors at Princess Margaret Cancer Centre and patient outcomes with genotype-matched clinical trials

被引：5
|
作者：
Bedard, Philippe L. [1 ]
Oza, Amit [1 ]
Clarke, Blaise [1 ]
Tsao, Ming-Sound [1 ]
Leighl, Natasha B. [1 ]
Chen, Eric X. [1 ]
Razak, Albiruni [1 ]
Berman, Hal K. [1 ]
Serra, Stefano [1 ]
Roehrl, Michael [1 ]
Califaretti, Nadia [2 ]
Trinkaus, Mateya [3 ]
Zhang, Tong [1 ]
Sukhai, Mahadeo A. [1 ]
Milea, Anca [1 ]
Hansen, Aaron R. [1 ]
Pugh, Trevor J. [1 ]
Stockley, Tracy [1 ]
Kamel-Reid, Suzanne [1 ]
Siu, Lillian L. [1 ]
机构：
[1] Princess Margaret Canc Ctr, Toronto, ON, Canada
[2] Grand River Reg Hosp, Kitchener, ON, Canada
[3] Markham Stouffville Hosp, Markham, ON, Canada
来源：
CLINICAL CANCER RESEARCH | 2016年 / 22卷
关键词：
D O I：
10.1158/1557-3265.PMSCLINGEN15-PR03
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PR03
引用
收藏
页数：3
相关论文
共 50 条
  • [41] Beyond traditional therapies: clinical significance of complex molecular profiling in patients with advanced solid tumours-results from a Turkish multi-centre study
    Olmez, Omer Fatih
    Bilici, Ahmet
    Er, Ozlem
    Bisgin, Atil
    Sevinc, Alper
    Akman, Tulay
    Uslu, Ruchan
    Mandel, Nil Molinas
    Yalcin, Suayib
    Teomete, Mehmet
    Gorumlu, Gurbuz
    Demir, Atakan
    Namal, Esat
    Alici, Suleyman
    Selcukbiricik, Fatih
    Bavbek, Sevil
    Paksoy, Fatma
    Basaran, Gul
    Ozer, Leyla
    Sener, Nur
    Harputluoglu, Hakan
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2024, 54 (05) : 562 - 568
  • [42] Outcomes of advanced gastrointestinal (GI) cancer patients in relationship to opioid use: An individual patient data pooled analysis from eight clinical trials
    Abdel-Rahman, Omar
    Karachiwala, Hatim
    Easaw, Jacob C.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (04)
  • [43] Overall survival is not a realistic end point for clinical trials of new drugs in advanced solid tumors: A critical assessment based on recently reported phase III trials in colorectal and breast cancer
    Di Leo, A
    Bleiberg, H
    Buyse, M
    JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (10) : 2045 - 2047
  • [44] Association between patient-reported outcomes and survival in HER2-positive advanced breast cancer: Pooled analysis of three clinical trials
    Modi, Natansh D.
    Abuhelwa, Ahmad Y.
    Danell, Nicolas O.
    Perry, Riley Na
    Rathod, Akash
    Badaoui, Sarah
    Sorich, Michael J.
    Hopkins, Ashley M.
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2021, 17 : 140 - 140
  • [45] ABCC2 polymorphisms and survival in the Princess Margaret cohort study and the NCIC clinical trials group BR. 24 trial of platinum-treated advanced stage non-small cell lung cancer patients
    Cuffe, Sinead
    Azad, Abul Kalam
    Qiu, Xiaoping
    Qiu, Xin
    Brhane, Yonathan
    Kuang, Qin
    Marsh, Sharon
    Savas, Sevtap
    Chen, Zhuo
    Cheng, Dangxiao
    Leighl, Natasha B.
    Goss, Glenwood
    Laurie, Scott A.
    Seymour, Lesley
    Bradbury, Penelope A.
    Shepherd, Frances A.
    Tsao, Ming Sound
    Chen, Bingshu E.
    Xu, Wei
    Liu, Geoffrey
    CANCER EPIDEMIOLOGY, 2016, 41 : 50 - 56
  • [46] Integrating multiplex and next generation sequencing (NGS) platforms in routine molecular profiling of metastatic breast cancer (MBC) patients (pts): Trends for enrollment in genotype-directed clinical trials (GDTs)
    Oliveira, M.
    Dienstmann, R.
    Bellet, M.
    Perez-Garcia, J. M.
    Gomez, P.
    Munoz-Couselo, E.
    Vidal, M.
    Ortega, V.
    Zamora, E.
    Soberino, J.
    Meire, A.
    Nuciforo, P.
    Vivancos, A.
    Cortes, J.
    Saura, C.
    CANCER RESEARCH, 2016, 76
  • [47] Final clinical outcomes of nationwide precision oncology pilot study; KOrean Precision Medicine Networking Group Study of MOlecular profiling guided therapy based on genomic alterations in advanced Solid tumors (KOSMOS) KCSG AL-20-05
    Kim, T-Y.
    Kim, S. Y.
    Kim, J. H.
    Jung, H. A.
    Choi, Y. J.
    Hwang, I. G.
    Cha, Y.
    Lee, G-W.
    Lee, Y-G.
    Kim, T. M.
    Lee, S-H.
    Lee, S.
    Yun, H.
    Choi, Y-L.
    Yoon, S.
    Han, S-W.
    Kim, T-Y.
    Kim, T. W.
    Zang, D. Y.
    Kang, J. H.
    ANNALS OF ONCOLOGY, 2023, 34 : S490 - S491
  • [48] Clinical-Prostate cancer Clinical outcomes and molecular profiling of advanced metastatic castration-resistant prostate cancer patients treated with 225Ac-PSMA-617 targeted alpha-radiation therapy
    van der Doelen, Maarten J.
    Mehra, Niven
    van Oort, Inge M.
    Looijen-Salamon, Monika G.
    Janssen, Marcel J. R.
    Custers, Jose A. E.
    Slootbeek, Peter H. J.
    Kroeze, Leonie, I
    Bruchertseifer, Frank
    Morgenstern, Alfred
    Haberkorn, Uwe
    Kratochwil, Clemens
    Nagarajah, James
    Gerritsen, Winald R.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2021, 39 (10) : 729.e7 - 729.e16
  • [49] PIK/AKT/MTOR pathway activation in triple negative breast cancer and outcomes with matched therapy in phase I clinical trials: Response in both patients with and without direct molecular alterations
    Gartesan, P.
    Moulder, S.
    Janku, F.
    Naing, A.
    Fu, S.
    Tsimberidou, A. M.
    Hong, D. D.
    Stephens, P.
    Yelensky, R.
    Meric, F.
    Kurzrock, R.
    Wheler, J. J.
    CANCER RESEARCH, 2013, 73
  • [50] Impact of open-label versus blinded study design on patient-reported outcomes data in randomized clinical trials of immunotherapy in advanced or metastatic cancer patients: a systematic review
    Anota, Amelie
    Pozet, Astrid
    Lemasson, Herve
    Cotte, Francois-Emery
    Falcoz, Antoine
    Eberst, Guillaume
    Mouillet, Guillaume
    Guerzider, Stephane
    Charton, Emilie
    Westeel, Virginie
    QUALITY OF LIFE RESEARCH, 2022, 31 (03) : 645 - 657
12345